Andere Sprachen ResMed, Inc.

Aktien

895878

US7611521078

RMD

Medizinische Ausrüstung

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 13.06.2025			% 5 Tage	% 1. Jan.
249,34 ^USD	-1,14 %		-1,13 %	+9,03 %

10.06.	CEO von ResMed verkauft Aktien im Wert von 2 Millionen US-Dollar	MT
06.06.	Laut einer aktuellen SEC-Meldung hat ein Insider von Resmed Aktien im Wert von 494.640 US-Dollar verkauft.	MT

Andere Sprachen

ResMed CEO Sells Shares Worth $2 Million	10.06.
Resmed Insider Sold Shares Worth $494,640, According to a Recent SEC Filing	06.06.
ResMed CFO Sells Shares	04.06.
Resmed Insider Sold Shares Worth $891,286, According to a Recent SEC Filing	27.05.
ResMed CFO Sells Shares	23.05.
Resmed Insider Sold Shares Worth $486,940, According to a Recent SEC Filing	22.05.
ResMed : Le succès d'Apnimed pèse sur Resmed	20.05.
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025	15.05.
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025	15.05.
Resmed Insider Sold Shares Worth $1,948,003, According to a Recent SEC Filing	09.05.
Resmed Insider Sold Shares Worth $484,500, According to a Recent SEC Filing	08.05.
ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum	02.05.
ResMed Buys VirtuOx for Undisclosed sum	01.05.
Resmed Acquires VirtuOx	01.05.
Resmed Acquires VirtuOx	01.05.
ResMed Inc. acquired VirtuOx, Inc.	01.05.
ResMed : Earnings Webcast Q3 2025 Transcript PDF	25.04.
Stocks in motion: IBM and Fiserv tumble on disappointing results	24.04.
Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.	24.04.
Make America Gamble Again	24.04.
En direct des marchés : déferlante de résultats avec Nestlé, Sanofi, Kering, Unilever, IBM, BNP et quelques centaines d'autres	24.04.
Australian Shares Rise Amidst Trump New China Tariff Plans; ResMed Posts Higher Fiscal Q3 Earnings, Revenue	24.04.
ResMed Posts Higher Fiscal Q3 Earnings, Revenue	24.04.
Resmed Posts Fiscal Q3 Non-GAAP EPS of $2.37, Revenue of $1.29 Billion	24.04.
ResMed slightly beats quarterly profit estimates, shrugs tariff concerns	24.04.

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ResMed, Inc.

Aktien

895878

US7611521078

RMD

Medizinische Ausrüstung

Andere Sprachen

Filter